T antigen is bound to a host protein in SY40-transformed cells (scientific article (publication date: 15 March 1979))

cites work (P2860)

Q24610856	100 years of Rous sarcoma virus
Q37589207	30 years and a long way into p53 research
Q55188514	40 Years of Research Put p53 in Translation.
Q36966801	55,000-dalton, retrovirus-associated, cell membrane glycoprotein: purification and quantitative measurements of expression in viruses, cells, and tissues
Q36906115	94,000- and 100,000-molecular-weight simian virus 40 T-antigens are associated with the nuclear matrix in transformed and revertant mouse cells
Q36276108	A 53-kilodalton protein common to chemically and virally transformed cells shows extensive sequence similarities between species
Q41289681	A Casein‐Kinase‐2‐Related Protein Kinase is Tightly Associated with the Large T Antigen of Simian Virus 40
Q36521889	A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
Q99549233	A Glance of p53 Functions in Brain Development, Neural Stem Cells, and Brain Cancer
Q35839765	A TEF-1-independent mechanism for activation of the simian virus 40 (SV40) late promoter by mutant SV40 large T antigens
Q35937193	A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18
Q53375840	A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas.
Q37249372	A complex barcode underlies the heterogeneous response of p53 to stress
Q68323916	A conformation hypothesis for the suppressor and promoter functions ofp53in cell growth control and in cancer
Q59053969	A deadly inheritance
Q33931645	A deletion in the simian virus 40 large T antigen impairs lytic replication in monkey cells in vivo but enhances DNA replication in vitro: new complementation function of T antigen
Q37697021	A direct effect of activated human p53 on nuclear DNA replication
Q48403147	A fragment of the SV40 large T-antigen gene transforms
Q36909664	A functional simian virus 40 origin of replication is required for the generation of a super T antigen with a molecular weight of 100,000 in transformed mouse cells
Q35842059	A herpesvirus saimiri protein required for interleukin-2 independence is associated with membranes of transformed T cells
Q35159385	A mouse mutant p53 product recognized by CD4+ and CD8+ T cells
Q37599465	A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs
Q30931923	A note from history: Landmarks in history of cancer, part 7.
Q33909710	A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer
Q47161106	A picorna-like virus suppresses the N-end rule pathway to inhibit apoptosis.
Q36081118	A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage
Q45769777	A research shortcut from a common cold virus to human cancer
Q34572898	A role for p53 in the frequency and mechanism of mutation
Q36848613	A short-lived nuclear phosphoprotein encoded by the human ets-2 proto-oncogene is stabilized by activation of protein kinase C.
Q34265353	A single gene and a pseudogene for the cellular tumour antigen p53.
Q53565320	A small subclass of SV40 T antigen binds to the viral origin of replication
Q77631505	A study on p53 protein and anti-p53 antibodies in the sera of patients with oesophageal cancer
Q45798150	A subclass of simian virus 40 T antigen with a high cell surface binding affinity
Q21559509	A very late viral protein triggers the lytic release of SV40
Q43481603	A wild-type p53 cytotoxic T cell epitope is presented by mouse hepatocarcinoma cells
Q36507746	Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50
Q36942353	Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species
Q38799291	Aberrant hnRNP K expression: All roads lead to cancer
Q36867443	Ability of a T-antigen transport-defective mutant of simian virus 40 to immortalize primary cells and to complement polyomavirus middle T in tumorigenesis
Q36792140	Ability of p53 and the adenovirus E1b 58-kilodalton protein to form a complex is determined by p53
Q41462464	Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas
Q45796894	Abortive transformation of rat 3Y1 cells by simian virus 40: Viral function overcoming inhibition of cellular proliferation under various conditions of culture
Q41304024	Accumulation of mutant p53 and hsp72 by heat treatment, and their association in a human glioblastoma cell line
Q67509681	Accumulation of p53 protein correlates with tumour proliferative activity in EBV positive Burkitt's lymphoma
Q36917280	Activated Ha-ras can cooperate with defective simian virus 40 in the transformation of nonestablished rat embryo fibroblasts
Q36782441	Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life
Q41210647	Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
Q36784121	Activation of ATPase activity of simian virus 40 large T antigen by the covalent affinity analog of ATP, fluorosulfonylbenzoyl 5'-adenosine
Q33707445	Activation of CREB/ATF sites by polyomavirus large T antigen
Q33958627	Activation of RNA polymerase III transcription in cells transformed by simian virus 40
Q45093761	Activation of cellular stress protein genes by herpes simplex virus temperature-sensitive mutants which overproduce immediate early polypeptides
Q40037740	Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
Q33542011	Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system
Q33964757	Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF.
Q37391112	Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation
Q64381309	Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells
Q33606342	Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73
Q40676317	Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells
Q36634353	Adenovirus type 9 E4 open reading frame 1 encodes a transforming protein required for the production of mammary tumors in rats
Q28756544	Advances in chemical carcinogenesis: a historical review and prospective
Q53472045	Alterations in oncogene expression and radiosensitivity in the most frequently used SV40-transformed human skin fibroblasts.
Q36827656	Alterations in the structure of new and old forms of simian virus 40 large T antigen (T) defined by age-dependent epitope changes: new T is the same as ATPase-active T.
Q36628203	Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas.
Q36698270	Alterations of the p53 gene in nasopharyngeal carcinoma
Q48067523	Alterations of the p53, Rb and MDM2 genes in osteosarcoma
Q89683056	Alternative Mechanisms of p53 Action During the Unfolded Protein Response
Q38179828	Alternative splicing in cancer: implications for biology and therapy
Q41633870	An SV40 transformation revertant due to a host mutation: Isolation and complementation analysis
Q45802726	An embryo protein induced by SV40 virus transformation of mouse cells
Q35999365	An equation to estimate the difference between theoretically predicted and SDS PAGE-displayed molecular weights for an acidic peptide
Q72523724	An immunohistochemical study of p53 and proliferating cell nuclear antigen expression in progressive multifocal leukoencephalopathy
Q40139690	An oligomeric form of simian virus 40 large T-antigen is immunologically related to the cellular tumor antigen p53
Q37286062	Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations
Q70524574	Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone
Q45841148	Analysis of simian virus 40 infection of CV-1 cells by quantitative two-color fluorescence with flow cytometry.
Q72892744	Analysis of the 84K, 55K, and 48K proteins immunoprecipitable by SV40 T antibody from SV40-infected and -transformed cells by tryptic peptide mapping on cation-exchange columns
Q43447920	Analysis of the nonviral antigens immunoprecipitable by SV40 T antibody from SV40-transformed human/mouse hybrid cell lines
Q37113813	Anaplastic renal carcinoma expressing SV40 T antigen in a female TRAMP mouse
Q42003660	Anatomy of Mdm2 and Mdm4 in evolution.
Q40277963	Anchorage independence: Analysis of factors affecting the growth and colony formation of wild-type and dl mutant SV40-transformed lines
Q35458911	Antibodies specific for the polyoma virus middle-size tumor antigen
Q41290168	Apoptosis and gastrointestinal pharmacology.
Q40551607	Apoptosis in viral infections
Q28611432	Apoptosis, cancer and the p53 tumour suppressor gene
Q41741254	Apoptosis, neurotrophic factors and neurodegeneration
Q91923602	Arnie Levine and the MDM2-p53 discovery: a postdoctoral fellow's perspective
Q92125253	Arnold J. Levine and my career development
Q92557659	Association Between Simian Virus 40 and Human Tumors
Q29620421	Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
Q41243025	Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cells.
Q41650259	Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma
Q36945858	Association of Simian Virus 40 T Antigen with the Nuclear Matrix of Infected and Transformed Monkey Cells
Q36830650	Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells
Q40307090	Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells
Q36913734	Association of adenovirus early-region 1A proteins with cellular polypeptides
Q36685815	Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations
Q40307715	Association of simian virus 40 T antigen with replicating nucleoprotein complexes of simian virus 40
Q38872379	Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End.
Q43756777	Autoimmune expression of a cytoplasmic protein p60 in mice bearing metastasizing SV40-transformed tumors
Q38066407	Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer
Q37043057	Autophagy: regulation and role in development
Q59049130	BAY 61-3606, CDKi, and Sodium Butyrate Treatments Modulate p53 Protein Level and Its Site-Specific Phosphorylation in Human Vestibular SchwannomasIn Vitro
Q33850208	Barrett's esophagus. Reducing the risk of progression to adenocarcinoma
Q92503902	Basal Level p53 Suppresses Antiviral Immunity against Foot-and-Mouth Disease Virus
Q38282236	Battle against cancer: an everlasting saga of p53.
Q38129174	Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy
Q73187748	Bcl-2 accelerates multistep prostate carcinogenesis in vivo
Q36532335	Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter
Q44167079	Binding of a simian virus 40 T antigen-related protein to DNA
Q36793131	Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen
Q40471781	Binding studies of SV40 T-antigen to SV40 binding site II
Q36936392	Biochemical Activities of T-Antigen Proteins Encoded by Simian Virus 40 A Gene Deletion Mutants
Q40067224	Biochemical characterization of Epstein-Barr virus nuclear antigen 2A
Q36931619	Biochemical properties of the 145,000-dalton super-T antigen from simian virus 40-transformed BALB/c 3T3 clone 20 cells
Q28078082	Biofilm Forming Lactobacillus: New Challenges for the Development of Probiotics
Q39819264	Biological and molecular analysis of p53 cellular-encoded tumor antigen
Q48320507	Biology and evolution of poorly differentiated neuroendocrine tumors
Q45797430	Biology of simian virus 40 (SV40) transplantation antigen (TrAg) X. Tumorigenic potential of mouse cells transformed by SV40 in high responder C57BL/6 mice and correlation with the persistence of SV40 TrAg, early proteins and viral sequences
Q44517202	Bovine papillomavirus E1 protein affects the host cell cycle phase fractions
Q59795032	Breaking Bad: How Viruses Subvert the Cell Cycle
Q35616131	CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation
Q47736161	CHARACTERIZATION OF THE MUCIN PHENOTYPE CAN PREDICT GASTRIC CANCER RECURRENCE AFTER ENDOSCOPIC MUCOSAL RESECTION.
Q26829232	Caloric restriction: is mammalian life extension linked to p53?
Q34568160	Cancer genetics: from Boveri and Mendel to microarrays
Q36921031	Candidate product of the FBJ murine osteosarcoma virus oncogene: characterization of a 55,000-dalton phosphoprotein
Q41072546	Capacity of UV-irradiated human fibroblasts to support adenovirus DNA synthesis correlates with transcription-coupled repair and is reduced in SV40-transformed cells and cells expressing mutant p53.
Q41198562	Casein kinase 2 inhibits the renaturation of complementary DNA strands mediated by p53 protein.
Q69612136	Cell cycle dependent genes inducible by different mitogens in cells from different species
Q38218288	Cell cycle regulation during viral infection
Q40442266	Cell cycle regulation in response to DNA damage in mammalian cells: A historical perspective
Q41514084	Cell specificity of transcription regulation by papovavirus T antigens and DNA replication
Q37177493	Cellular adaptation to hypoxia and p53 transcription regulation
Q37417605	Cellular and sub-cellular responses to UVA in relation to carcinogenesis
Q35981213	Cellular factors required for multiple stages of SV40 DNA replication in vitro
Q43927270	Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53
Q36503362	Cellular proteins associated with simian virus 40 early gene products in newly infected cells
Q40145588	Cellular proteins reactive with monoclonal antibodies directed against simian virus 40 T-antigen
Q36561672	Cellular transformation and malignancy induced by ras require c-jun
Q34985587	Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens
Q90642065	Ceramide Signaling and p53 Pathways
Q41454671	Characterization by human autoantibody of a nuclear antigen related to the cell cycle
Q33403060	Characterization of SV-40 Tag rats as a model to study prostate cancer
Q41341089	Characterization of a murine p53SER246 mutant equivalent to the human p53SER249 associated with hepatocellular carcinoma and aflatoxin exposure
Q45801837	Characterization of a temperature-sensitive, DNA-positive, nontransforming mutant of simian virus 40
Q36906979	Characterization of am404, an amber mutation in the simian virus 40 T antigen gene
Q40266110	Characterization of different tumor antigens present in cells transformed by simian virus 40
Q53556960	Characterization of human p53 antigens employing primate specific monoclonal antibodies
Q40660065	Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells
Q38507377	Characterization of rat spiral ligament cell line immortalized by adenovirus 12-simian virus 40 hybrid virus
Q36876699	Characterization of simian virus 40 large T antigen by using different monoclonal antibodies: T-p53 complexes are preferentially ATPase active and adenylylated
Q36507665	Characterization of tau antigens isolated from uninfected and simian virus 40-infected monkey cells and papovavirus-transformed cells
Q40669877	Characterization of the human p53 gene
Q36955441	Characterization of the protein apparently responsible for the elevated tyrosine protein kinase activity in LSTRA cells
Q38960399	Characterization, expression and silencing by RNAi of p53 from Penaeus monodon
Q40674478	Chromosomal Assignment of the Murine Gene Encoding the Transformation-Related Protein p53
Q40931241	Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance
Q37973676	Chromosome instability and deregulated proliferation: an unavoidable duo.
Q28201920	Clinical and Pathologic Relevance of p53 Index in Canine Osseous Tumors
Q77711290	Clinical implications of molecular abnormalities in lung cancer
Q48011034	Clinical significance of detecting p53 protein in Burkitt lymphoma and B-cell acute lymphoblastic leukemia using immunocytochemistry
Q27002356	Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer
Q40461080	Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53.
Q36660357	Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.
Q26752209	CncRNAs: RNAs with both coding and non-coding roles in development
Q72352371	Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients
Q33826650	Common threads in persistent viral infections
Q36301535	Comparative analysis of p73 and p53 regulation and effector functions
Q42281113	Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas
Q38632111	Comparisons between murine polyomavirus and Simian virus 40 show significant differences in small T antigen function
Q36798180	Complex formation between the lymphotropic papovavirus large tumor antigen and the tumor suppressor protein p53.
Q40064063	Complex formation of human T-cell leukemia virus type I p40tax transactivator with cellular polypeptides.
Q33589833	Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
Q40308362	Complex formation of simian virus 40 large T antigen with cellular protein p53.
Q35299950	Complex of simian virus 40 large tumor antigen and 48,000-dalton host tumor antigen
Q35235746	Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells
Q38313400	Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants.
Q36574046	Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression
Q36832520	Constitutive expression of simian virus 40 large T antigen in monkey cells activates their capacity to support polyomavirus replication
Q36923165	Construction and Characterization of Viable Deletion Mutants of Simian Virus 40 Lacking Sequences near the 3′ End of the Early Region
Q24633347	Contagious cancer
Q58546230	Contribution of DNA replication to the FAM111A-mediated simian virus 40 host range phenotype
Q47671672	Control mechanisms in germ cells mediated by p53 family proteins.
Q36397275	Control of cell migration: a tumour suppressor function for p53?
Q28236097	Control of the G2/M transition
Q38113943	Control the host cell cycle: viral regulation of the anaphase-promoting complex
Q36945247	Conversion Through Homologous Recombination of the Gene Encoding Simian Virus 40 115,000-Molecular-Weight Super T Antigen to a Gene Encoding a Normal-Size Large T Antigen Variant
Q53548575	Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.
Q47791886	Cooperation of a single lysine mutation and a C-terminal domain in the cytoplasmic sequestration of the p53 protein
Q41636011	Cooperation of p53 and polyoma virus middle T antigen in the transformation of primary rat embryo fibroblasts
Q38290890	Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation
Q57268282	Coordinate expression of the 48K host nuclear phosphoprotein and SV40 T Ag upon primary infection of mouse cells
Q44557313	Correlated abnormalities of transforming growth factor-β1 response and p53 expression in thyroid epithelial cell transformation
Q44517585	Correlation of p53 protein expression in human urothelial transitional cell cancers with malignant potential and patient survival
Q37254784	Correlation of transcription of MALAT-1, a novel noncoding RNA, with deregulated expression of tumor suppressor p53 in small DNA tumor virus models
Q24301537	Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor
Q36510188	Cul7/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation
Q40491794	Current Topics of Immunohistochemistry as Applied to Skin Tumors
Q45947167	Cytokine-induced modulation of tumor suppressor gene expression in ovarian cancer cells: up-regulation of p53 gene expression and induction of apoptosis by tumor necrosis factor-alpha.
Q43140225	Cytoplasmic sequestration of p53 promotes survival in leukocytes transformed by Theileria
Q38316929	DNA Structure and Polymerase Fidelity: A New Role for A-DNA.
Q91983815	DNA Tumor Viruses and Their Contributions to Molecular Biology
Q30842780	DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression.
Q58052330	Data Integration: Towards Understanding Biological Complexity
Q71560974	Decreasing p53 overexpression in sequential, recurrent, oral squamous cell carcinomas
Q38332737	Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation
Q36835468	Deletion of 5'-coding sequences of the cellular p53 gene in mouse erythroleukemia: a novel mechanism of oncogene regulation
Q61449903	Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
Q35941628	Deregulation of the cell cycle by the Epstein-Barr virus
Q35235163	Detection and characterization of multiple forms of simian virus 40 large T antigen
Q72908880	Detection and characterization of viral genomes and search for tumoral antigens in two hamster cell lines derived from tumors induced by bovine papillomavirus type 1
Q45613582	Detection and expression of human BK virus sequences in neoplastic prostate tissues
Q72608634	Detection of P53 tumor-suppressor-gene protein in bladder tumors and prostate cancer: possible clinical implications
Q35298187	Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein
Q57211763	Detection of a novel, primate-specific 'kill switch' tumor suppression mechanism that may fundamentally control cancer risk in humans: an unexpected twist in the basic biology of TP53
Q46456704	Detection of p53 gene mutations in oral squamous cell carcinomas of a black African population sample
Q42487822	Detection of p53 protein and Ki-67 proliferation antigen in human papillomavirus (HPV)-positive and HPV-negative cervical lesions by immunohistochemical double-staining
Q37949279	Development of new cell lines for animal cell biotechnology
Q41062527	Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells
Q36536905	Diagnostic utility of oncogenes and their products in human cancer
Q33997846	Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress
Q36940094	Different forms of simian virus 40 large tumor antigen varying in their affinities for DNA
Q41155486	Differential Taxol-dependent arrest of transformed and nontransformed cells in the G1 phase of the cell cycle, and specific-related mortality of transformed cells
Q36888762	Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells.
Q35871078	Differential interaction of temperature-sensitive simian virus 40 T antigens with tumor suppressors pRb and p53
Q40829313	Differential phosphorylation of mitogen-activated protein kinase families by epidermal growth factor and ultraviolet B irradiation in SV40-transformed human keratinocytes
Q28572538	Differential protein expression, DNA binding and interaction with SV40 large tumour antigen implicate the p63-family of proteins in replicative senescence
Q40131883	Dimers and complexes with p53 are the prevalent oligomeric forms of a transforming nonkaryophilic T antigen of simian virus 40.
Q36841865	Discontinuous native protein gel electrophoresis: pros and cons
Q33738750	Discovery of Mieap-regulated mitochondrial quality control as a new function of tumor suppressor p53
Q34060590	Discovery of a p53 variant that controls metastasis
Q36921966	Discrete regions of simian virus 40 large T antigen are required for nonspecific and viral origin-specific DNA binding
Q64956138	Discussion of some 'knowns' and some 'unknowns' about the tumour suppressor p53.
Q34537149	Disruption of oncogene/tumor suppressor networks during human carcinogenesis
Q40554501	Distinct functions for WRN and TP53 in a shared pathway of cellular response to 1-beta-D-arabinofuranosylcytosine and bleomycin.
Q39744147	Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas
Q42072409	Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.
Q73960260	Does p53 immunostaining improve diagnostic accuracy in urine cytology?
Q37229811	Double immunostaining for p53 and molecular chaperone hsp72/73 in gastric carcinoma
Q42945496	Down-regulation of p53 by double-stranded RNA modulates the antiviral response
Q35101871	Drug discovery and p53.
Q36387594	Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity
Q36910554	Dynamic nature of the association of large tumor antigen and p53 cellular protein with the surfaces of simian virus 40-transformed cells
Q35206764	E1A signaling to p53 involves the p19(ARF) tumor suppressor
Q40896659	E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage
Q36358319	EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.
Q33915487	Effect of a tsA mutation of simian virus 40 late gene expression: variations between host cell lines
Q45807849	Effect of simian virus 40 infection on albumin production by hepatocytes cultured in chemically defined medium and plated on collagen and non-collagen attachment surfaces
Q38348780	Effects of 2-amino-4,6-dinitrotoluene on p53 tumor suppressor gene expression
Q29619196	Effects of an Rb mutation in the mouse
Q35993764	Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck.
Q42510424	Elevated levels of the p53 tumour suppressor protein in the basal layer of recurrent laryngeal papillomas
Q28077156	Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness
Q35551117	Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability.
Q64374614	Encounters with adenovirus
Q36941962	Energy Requirement for Degradation of Tumor-Associated Protein p53
Q34050026	Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells.
Q92860212	Enzymatic Degradation of Biofilm by Metalloprotease From Microbacterium sp. SKS10
Q33839135	Epidemiology and molecular genetics of colorectal cancer
Q40136771	Epstein-Barr virus (EBV), lymphocytes and transformation
Q38356037	Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity
Q34326542	Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies
Q55395428	Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer.
Q36845840	Evidence for a structural relationship between BRCT domains and the helicase domains of the replication initiators encoded by the Polyomaviridae and Papillomaviridae families of DNA tumor viruses.
Q42930582	Evidence for modulation of BAG3 by polyomavirus JC early protein.
Q36830520	Evolutionary conservation of the biochemical properties of p53: specific interaction of Xenopus laevis p53 with simian virus 40 large T antigen and mammalian heat shock proteins 70
Q36724486	Excess wild-type p53 blocks initiation and maintenance of simian virus 40 transformation
Q36547790	Exploiting the p53 pathway for the diagnosis and therapy of human cancer.
Q37083966	Expression and interactions of human adenovirus oncoproteins
Q36859189	Expression of 100,000-Mr simian virus 40 (SV40) tumor antigen in mouse fibroblasts transfected with replication-defective SV40 genomes
Q73719734	Expression of PCNA and p53 in esophageal dysplasia and esophageal carcinoma
Q45801095	Expression of SV40 T antigen polypeptides in cells biochemically transformed by plasmids containing the herpes simplex virus thymidine kinase gene and the genome of an SV40tsA mutant
Q40675623	Expression of Simian Virus 40 Large T Antigen in Embryonal Carcinoma Cell Hybrids
Q28287375	Expression of a candidate ataxia-telangiectasia group D gene in cultured fibroblast cell lines and human tissues
Q36932745	Expression of a transformation-related protein (p53) in the malignant stage of Friend virus-induced diseases
Q34378463	Expression of mutant p53 protein in hepatocellular carcinoma
Q35984818	Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder
Q35903258	Expression of p24, a novel p21Waf1/Cip1/Sdi1-related protein, correlates with measurement of the finite proliferative potential of rodent embryo fibroblasts
Q35522870	Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions
Q72089540	Expression of p53 product in Chinese human bladder carcinoma
Q36235611	Expression of simian virus 40 large T (tumor) oncogene in mouse chondrocytes induces cell proliferation without loss of the differentiated phenotype
Q37428803	Extensive post-translational modification of active and inactivated forms of endogenous p53.
Q38363488	F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4.
Q40466587	Familial breast cancer and genes involved in breast carcinogenesis
Q30669552	Feedback regulation between orphan nuclear receptor TR2 and human papilloma virus type 16.
Q73102796	Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance
Q36309667	Fragments of the simian virus 40 transforming gene facilitate transformation of rat embryo cells
Q36863092	Free and viral chromosome-bound simian virus 40 T antigen: changes in reactivity of specific antigenic determinants during lytic infection
Q36729673	Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines
Q38705286	Friend virus-induced erythroleukemia: a multistage malignancy
Q36686649	From growth arrest to growth suppression
Q34164614	From p63 to p53 across p73.
Q64102183	Functional Diversity of p53 in Human and Wild Animals
Q36648185	Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency
Q36637002	Functional characterization of Xenopus laevis p53: evidence of temperature-sensitive transactivation but not of repression
Q36685139	Functional characterization of temperature-sensitive mutants of simian virus 40 large T antigen
Q43772756	Functional consequences of oncogene-induced photoreceptor degeneration in transgenic mice
Q36698048	Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression
Q38300638	Functional inactivation but not structural mutation of p53 causes liver cancer.
Q40107890	Functional interaction of nuclear transport-defective simian virus 40 large T antigen with chromatin and nuclear matrix
Q36873869	Functional role of BK virus tumor antigens in transformation
Q40101353	Functions of T antigens of SV40 and polyomavirus
Q35976056	Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes
Q72661833	Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method
Q41844172	Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines
Q40849028	Gene therapy for colon cancer.
Q33755140	Gene therapy using SV40-derived vectors: what does the future hold?
Q41051771	Generation and characterization of an immortal cell line of xeroderma pigmentosum group E.
Q36845425	Generation of murine stromal cell lines supporting hematopoietic stem cell proliferation by use of recombinant retrovirus vectors encoding simian virus 40 large T antigen
Q54966492	Genetic Alteration of p53 in Some Patients with Adult T-Cell Leukemia
Q34813092	Genetic alterations in ovarian cancer cells that might account for sensitivity to chemotherapy in patients.
Q35861223	Genetic analysis of polyomavirus large T nuclear localization: nuclear localization is required for productive association with pRb family members.
Q36903846	Genetic and biochemical analysis of transformation-competent, replication-defective simian virus 40 large T antigen mutants
Q34438119	Genetic predisposition to cancer and familial cancer syndromes
Q38068825	Genome guardian p53 and viral infections
Q36642204	Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
Q36493335	Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management.
Q34057911	Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes.
Q41816411	Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome
Q33534212	Gliomas
Q35230883	Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.
Q42819146	Growth regulation of a cellular tumour antigen, p53, in nontransformed cells
Q37421517	Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression
Q40720204	HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis
Q36872778	HSP70 binding sites in the tumor suppressor protein p53.
Q40794530	Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis
Q35101216	Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
Q28569202	Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3
Q38309880	Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability
Q50856462	Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C.
Q56928447	Hereditary breast cancer
Q40970549	Hereditary cancer: two hits revisited
Q41562003	Herpes simplex virus infection causes the accumulation of a heat-shock protein
Q40755915	Hetero-oligomerization does not compromise 'gain of function' of tumor-derived p53 mutants
Q34091002	Heterochromatin silencing of p53 target genes by a small viral protein
Q37605827	Heterogeneity of Li-Fraumeni syndrome links to unequal gain-of-function effects of p53 mutations.
Q53418672	Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression.
Q55037712	High frequency of p53 abnormality in laryngeal cancers of heavy smokers and its relation to human papillomavirus infection.
Q36760672	High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene
Q35833598	High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma
Q35823973	High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas
Q39875158	High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.
Q38019869	History of protein-protein interactions: from egg-white to complex networks
Q70197165	Hormone-dependent enhancement of neoplastic phenotype expression by MuMTV-infected heterologous cells, and MuMTV-induced cellular antigens
Q36350356	Host nuclear proteins expressed in simian virus 40-transformed and -infected cells
Q36667622	Hot-spot p53 mutants interact specifically with two cellular proteins during progression of the cell cycle
Q91701456	How TP53 (almost) became an oncogene
Q38170081	How do I kill thee? Let me count the ways: p53 regulates PARP-1 dependent necrosis
Q38367375	How do viruses control mitochondria-mediated apoptosis?
Q74266124	How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone?
Q91533177	How mutant p53 empowers Foxh1 fostering leukaemogenesis?
Q36102815	Human BK Polyomavirus-The Potential for Head and Neck Malignancy and Disease
Q24609227	Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator
Q24562978	Human TAFII31 protein is a transcriptional coactivator of the p53 protein
Q35873729	Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription
Q40046680	Human oncogenic viruses: nature and discovery
Q58131437	Human p53 and Hdm2: Cloning and Construction of Expression Plasmid
Q40678382	Human p53 inhibits growth in Schizosaccharomyces pombe
Q33643799	Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2
Q41098425	Human papillomavirus (HPV) 16 E6 sensitizes cells to atractyloside-induced apoptosis: role of p53, ICE-like proteases and the mitochondrial permeability transition
Q28187745	Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription
Q36893766	Human polyomavirus JC virus genome
Q45137833	Human thymic epithelial cells are frequently transformed by retroviral vectors encoding simian virus 40
Q36507591	Identification and initial characterization of a new low-molecular-weight virus-encoded T antigen in a line of simian virus 40-transformed cells
Q36930790	Identification of B-lymphotropic papovavirus-coded proteins.
Q37068526	Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes
Q24337360	Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirus
Q29620442	Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product
Q37212448	Identification of new p53 acetylation sites in COS-1 cells
Q36867104	Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex
Q37731374	Identification of two p53 isoforms from Litopenaeus vannamei and their interaction with NF-κB to induce distinct immune response
Q30987442	Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression
Q38045922	Imidazoline derivatives: a patent review (2006--present).
Q34019492	Immortalization of a primate bipotent epithelial liver stem cell
Q26829548	Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons
Q53482889	Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells
Q73223966	Immunohistochemical Detection of p53 and c-erbB-2 Proteins: Prognostic Significance in Operable Breast Cancer
Q70641343	Immunohistochemical detection of the p53 oncoprotein in tumours of melanocytic origin
Q71797512	Immunohistochemical expression of p53 protein and proliferating cell nuclear antigen in hepatocellular carcinoma
Q35832962	Immunohistochemical study of p53 in human lung carcinomas.
Q43444816	Immunophenotype of SV40-T gene transfected epithelial cell lines derived from human benign breast tumors
Q36918852	Immunoprecipitation of some forms of simian virus 40 large-T antigen by antibodies to synthetic peptides
Q62631293	Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population
Q35111076	Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53.
Q35123468	Improving cancer therapy by non-genotoxic activation of p53.
Q33767424	In situ detection of apoptosis at sites of chronic bacterially induced inflammation in human gingiva
Q55240856	In situ polymerase chain reaction detection of HTLV-I provirus and expression of the p53 tumor suppressor gene in infiltrating cells in skeletal muscle from a patient with adult T cell leukemia.
Q40666508	In vitro expression of human p53 cDNA clones and characterization of the cloned human p53 gene
Q72399727	In vitro mutagenesis of a putative DNA binding domain of SV40 large-T
Q39873297	In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes
Q33629594	In vivo recombinant adenovirus-mediated p53 gene therapy in a syngeneic rat model for colorectal cancer
Q40675444	Inactivation of p53 Gene Expression by an Insertion of Moloney Murine Leukemia Virus-Like DNA Sequences
Q39870530	Inactivation of the retinoblastoma susceptibility protein is not sufficient for the transforming function of the conserved region 2-like domain of simian virus 40 large T antigen.
Q35237286	Increased concentration of an apparently identical cellular protein in cells transformed by either Abelson murine leukemia virus or other transforming agents
Q35609543	Increased expression of p53 protein in human leukemia cells
Q37013182	Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.
Q36891202	Induction of cellular DNA synthesis by a simian virus 40 mutant defective in nuclear transport of T antigen
Q34127232	Induction of interferon-stimulated genes by Simian virus 40 T antigens
Q41371638	Induction of interleukin-2 transcription by the hamster polyomavirus middle T antigen: a role for Fyn in T cell signal transduction
Q33656171	Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells
Q42281248	Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer
Q24317013	Inhibition of p53 DNA binding by human papillomavirus E6 proteins
Q39606488	Inhibition of p53 tumor suppressor by viral interferon regulatory factor
Q40038319	Inhibition of p53-mediated transactivation by E6 of type 1, but not type 5, 8, or 47, human papillomavirus of cutaneous origin.
Q40066650	Inhibition of viral and cellular promoters by human wild-type p53
Q37855826	Inhibitors of MDM2 and MDMX: a structural perspective.
Q41500820	Initiation of autoimmunity to self-proteins complexed with viral antigens
Q36362919	Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen
Q43131463	Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins
Q41461437	Integration of Ecogpt and SV40 early region sequences into human chromosome 17: a dominant selection system in whole cell and microcell human-mouse hybrids
Q36935658	Interaction Between the Rous Sarcoma Virus Transforming Protein and Two Cellular Phosphoproteins: Analysis of the Turnover and Distribution of This Complex
Q24547088	Interaction between the N-terminus of human topoisomerase I and SV40 large T antigen
Q36579279	Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses
Q33292223	Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins
Q22008057	Interaction of the single-stranded DNA-binding protein Puralpha with the human polyomavirus JC virus early protein T-antigen
Q28776004	Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway
Q36920345	Interactions between polyomavirus medium T antigen and three cellular proteins of 88, 61, and 37 kilodaltons
Q45806859	Intercellular communication and the control of growth: XII. Alteration of junctional permeability by simian virus 40. Roles of the large and small T antigens
Q42818894	Intermolecular phosphorylation between insulin holoreceptors does not stimulate substrate kinase activity
Q36604805	Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors
Q36384554	Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage.
Q40134237	Intracellular location and kinetics of complex formation between simian virus 40 T antigen and cellular protein p53
Q34812489	Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53
Q35103185	Introduction: The Changing Directions of p53 Research
Q37352771	Investigations on a clinically and functionally unusual and novel germline p53 mutation
Q36318172	Involvement of PP2A in viral and cellular transformation
Q41592444	Involvement of p53 in cell differentiation and development
Q36167487	Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis.
Q24555633	Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene
Q24318228	Isolation and identification of the human homolog of a new p53-binding protein, Mdmx
Q44645744	Isolation and partial characterization of a 55,000-dalton protein induced in cells transformed by the ml strain of moloney murine sarcoma virus
Q40665592	Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule
Q39585155	J domain-independent regulation of the Rb family by polyomavirus large T antigen
Q42828333	JC virus large T protein transforms rodent cells but is not involved in human medulloblastoma
Q40849418	Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia
Q41188296	Laboratory probing of oncogenes from human liquid and solid specimens as markers of exposure to toxicants
Q41249912	Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions
Q40820817	Lack of ultraviolet-light inducibility of the medakafish (Oryzias latipes) tumor suppressor gene p53.
Q36867876	Large T antigens of simian virus 40 and polyomavirus efficiently establish primary fibroblasts
Q34432117	Li-Fraumeni syndrome – a molecular and clinical review
Q34618683	Likelihood Models of Somatic Mutation and Codon Substitution in Cancer Genes
Q36831658	Linker insertion mutants of simian virus 40 large T antigen that show trans-dominant interference with wild-type large T antigen map to multiple sites within the T-antigen gene
Q33870289	Liver-directed gene therapy: promises, problems and prospects at the turn of the century
Q59057697	Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells
Q36938740	Localization of the Adenovirus E1Aa Protein, a Positive-Acting Transcriptional Factor, in Infected Cells Infected Cells
Q36695353	Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins
Q36685600	Long-term gene expression in dividing and nondividing cells using SV40-derived vectors.
Q80586970	Loss of c-abl facilitates anchorage-independent growth of p53- and RB- deficient primary mouse embryonic fibroblasts
Q39455963	Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation
Q36828231	Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells
Q40794489	Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity
Q53385488	Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic mice.
Q36897933	MC29 virus-coded protein occurs as monomers and dimers in transformed cells
Q41633106	MDM2--arbiter of p53's destruction
Q52340395	MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?
Q24561971	MDMX: a novel p53-binding protein with some functional properties of MDM2
Q37676784	Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells
Q35977776	Malignant progression of SV40-immortalised human milk epithelial cells
Q35589990	Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells
Q28609886	Mapping of the p53 and mdm-2 Interaction Domains
Q35235117	Mapping of the viral mRNA encoding a super-T antigen of 115,000 daltons expressed in simian virus 40-transformed rat cell lines
Q27025941	Matrix and backstage: cellular substrates for viral vaccines
Q36386557	Mechanism of interferon action: Simian virus 40-specific early polypeptides synthesized in untreated and interferon-treated monkey kidney cells
Q73320007	Mechanism of p53 degradation
Q36273391	Mechanisms and markers of carcinogenesis and neoplastic progression
Q40667913	Mechanisms of action of the p53 tumor suppressor and prospects for cancer gene therapy by reconstitution of p53 function
Q36698827	Mechanisms of interference with simian virus 40 (SV40) DNA replication by trans-dominant mutants of SV40 large T antigen
Q33722859	Mechanisms of p53 loss in human sarcomas
Q36884544	Medium tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with 73-kilodalton heat shock protein
Q37067101	Merkel cell carcinoma: a virus-induced human cancer
Q34947967	Merkel cell polyomavirus large T antigen disrupts lysosome clustering by translocating human Vam6p from the cytoplasm to the nucleus
Q36468289	Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential
Q34309882	Merkel cell polyomavirus: molecular insights into the most recently discovered human tumour virus
Q64078232	Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells
Q43665417	Metastasizing neuroblastomas from taste buds in rats transgenic for the Simian virus 40 large T antigen under control of the probasin gene promoter
Q29547697	Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Q26785743	Microbial Regulation of p53 Tumor Suppressor
Q36316665	Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells
Q37576004	Micrometastasis expressing insulin arise in lung and spleen at advanced stage of rip1-tag2 transgenic mice
Q90421599	Miles to go (mtgo) encodes FNDC3 proteins that interact with the chaperonin subunit CCT3 and are required for NMJ branching and growth in Drosophila
Q40399548	Mitochondrial localization of p53 during adenovirus infection and regulation of its activity by E1B-19K.
Q58695374	Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers
Q29615657	Modes of p53 regulation
Q37512255	Modulation of autophagy-like processes by tumor viruses
Q40062749	Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression.
Q36925553	Modulation of p53 protein expression during cellular transformation with simian virus 40
Q35367195	Molecular biology in the diagnosis and prognosis of solid and lymphoid tumors
Q41131665	Molecular biology of pediatric gliomas
Q39726667	Molecular biology of the cell cycle
Q36489098	Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.
Q41353388	Molecular genetics of colorectal cancer (part 1).
Q30495393	Molecular genetics of neurological tumours
Q36827597	Molecular mechanisms in lung pathogenesis
Q30498610	Molecular mechanisms of cancer
Q33368199	Molecular pathogenesis of colorectal cancer
Q29616471	Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
Q33920832	Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens
Q35235589	Monoclonal antibodies against simian virus 40 tumor antigens: analysis of antigenic binding sites, using adenovirus type 2-simian virus 40 hybrid viruses
Q33933776	Monoclonal antibodies displaying a novel species specificity for the primate transformation-related protein, p53.
Q34249232	Monoclonal antibodies specific for simian virus 40 tumor antigens
Q36347553	Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny
Q40127251	Monoclonal antibody analysis of p53 expression in normal and transformed cells
Q40116257	Monoclonal antibody analysis of simian virus 40 small t-antigen expression in infected and transformed cells
Q26746524	Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX
Q38351451	Mouse RAD50 has limited epitopic homology to p53 and is expressed in the adult myocardium
Q36436702	Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo
Q38447567	Mouse lung neuroendocrine carcinomas: distinct morphologies, same transcription factors.
Q58693513	Mouse models of prostate cancer
Q46905586	Mouse p53 inhibits SV40 origin-dependent DNA replication
Q44673371	Mouse polyomavirus large T antigen inhibits cell growth and alters cell and colony morphology in Saccharomyces cerevisiae.
Q42526715	Multiple mechanisms contribute to the activation of RNA polymerase III transcription in cells transformed by papovaviruses
Q48026339	Multisite phosphorylation and the integration of stress signals at p53.
Q36736774	Murine Gammaherpesvirus 68 LANA and SOX Homologs Counteract ATM-Driven p53 Activity during Lytic Viral Replication
Q40410709	Murine models of neoplasia: functional analysis of the tumour suppressor genes Rb-1 and p53.
Q41519041	Musculoskeletal oncology--advances in cytogenetics and molecular genetics and their clinical implications
Q30354662	Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.
Q36920336	Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1
Q36698822	Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity
Q35081210	Mutant p53 cooperates with knockdown of endogenous wild-type p53 to disrupt tubulogenesis in Madin-Darby canine kidney cells
Q38204111	Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks
Q36661775	Mutant p53 proteins: between loss and gain of function
Q36777355	Mutant p53: an oncogenic transcription factor
Q36070574	Mutant p53: one name, many proteins
Q40951665	Mutation and cancer: a personal odyssey
Q36780709	Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation
Q40535104	Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53.
Q36803951	Mutation of the serine 312 phosphorylation site does not alter the ability of mouse p53 to inhibit simian virus 40 DNA replication in vivo
Q36936356	Mutational Analysis of Simian Virus 40 T Antigen: Isolation and Characterization of Mutants with Deletions in the T-Antigen Gene
Q33940332	Mutational analysis of simian virus 40 large T antigen DNA binding sites
Q47691368	Mutations in context: implications of BRCA testing in diverse populations
Q35982987	Mutations in p53 do not account for heritable breast cancer: a study in five affected families
Q37599484	Mutations in the bovine leukemia virus Tax protein can abrogate the long terminal repeat-directed transactivating activity without concomitant loss of transforming potential
Q74597212	Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis
Q28249770	Mutations in the p53 gene occur in diverse human tumour types
Q40771480	Mutations of the p53 gene in B-cell lymphoma
Q40924895	Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
Q40062939	Mutual functional antagonism of the simian virus 40 T antigen and the hepatitis B virus trans activator
Q39077362	Negative auto-regulators trap p53 in their web.
Q45869640	Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy
Q33740135	Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
Q39007820	Neomorphic mutations create therapeutic challenges in cancer.
Q46821463	Neoplastic transformation and angiogenesis in the thymus of transgenic mice expressing SV40 T and t antigen under an L-pyruvate kinase promoter (SV12 mice).
Q26825296	Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator
Q36976531	New Properties of Simian Virus 40 Large T Antigen
Q54169975	New aspects of cell biology in osteosarcoma.
Q34047246	New insights into p53 regulation and gene therapy for cancer.
Q38389967	New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy.
Q41741132	No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen
Q94475905	Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma
Q36969363	Nonlytic Simian Virus 40-Specific 100K Phosphoprotein Is Associated with Anchorage-Independent Growth in Simian Virus 40-Transformed and Revertant Mouse Cell Lines
Q36288245	Nonselective expression of simian virus 40 large tumor antigen fragments in mouse cells
Q40647696	Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis
Q36346972	Nuclear antigen detected in hepatoma cell lines containing integrated hepatitis B virus DNA
Q24310625	Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization
Q55282601	Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer
Q40818113	Nuclear protein p68 is an RNA-dependent ATPase
Q40115140	Nuclear subcompartmentalization of simian virus 40 large T antigen: evidence for in vivo regulation of biochemical activities
Q34115253	ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus
Q40129645	Oligomerization of oncoprotein p53.
Q26830643	Oncogenes and RNA splicing of human tumor viruses
Q36874460	Oncogenes and anti-oncogenes; the molecular basis of tumour behaviour
Q41485266	Oncogenes and antioncogenes in the development of HPV associated tumors
Q35034093	Oncogenes and tumor-suppressor genes
Q39743389	Oncogenes, cancer and analytical cytology
Q26749382	Oncogenic Intra-p53 Family Member Interactions in Human Cancers
Q64517981	Oncogenic intelligence: Cell immortalization and transformation by the p53 gene
Q37857673	One function--multiple mechanisms: the manifold activities of p53 as a transcriptional repressor
Q37817494	Oral lichen planus and the p53 family: what do we know?
Q39007931	Osteocytes serve as a progenitor cell of osteosarcoma
Q67970173	Overexpression of p53 in head and neck cancer
Q38045766	Overexpression of p53 protein in human tumors
Q43972822	Overexpression of p73 causes apoptosis in vascular smooth muscle cells
Q41489317	Overexpression of the MDM2 oncogene in leukemia and lymphoma
Q35992950	Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma
Q37058260	Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I
Q36897747	Overproduction of protein p53 contributes to simian virus 40-mediated transformation
Q41108776	P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes?
Q72350615	P53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer
Q92732638	P53 and The Immune Response: 40 Years of Exploration-A Plan for the Future
Q53418486	P53 and cyclin D1 staining patterns of malignant and premalignant oral lesions in age-dependent populations.
Q44327720	P53 family proteins provide new insights into lung carcinogenesis and clinical treatment
Q26771603	P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development
Q40958072	P53 gene mutations in lymphoid diseases and their possible relevance to drug resistance
Q36216684	P53 in cancer: a paradigm for modern management of cancer
Q34546732	P53 is a tumor suppressor gene
Q34287830	P53 mdm2 inhibitors
Q33899383	P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.
Q71219510	P53 protein expression in pancreatic tumors and its relationship to clinicopathological factors and prognosis
Q78792241	P53 protein expression in transitional cell carcinoma of the bladder - experience of the University of Malaya Medical Centre
Q33933630	P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibroblasts
Q28611354	P53, apoptosis, and breast cancer
Q28611435	P53, cell cycle control and apoptosis: Implications for cancer
Q36346951	P80: a tumor-related protein found in many lymphomas of mice
Q35832827	Pancreatic adenocarcinomas frequently show p53 gene mutations.
Q42065661	Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens
Q37680961	Patented inhibitors of p53-Mdm2 interaction (2006 - 2008).
Q41510725	Pathways of p53-dependent apoptosis.
Q33932090	Permanent expression of p53 in FR 3T3 rat cells but cell cycle-dependent association with large-T antigen in simian virus 40 transformants
Q40135384	Phenotypic and Cytogenetic Characteristics of Human B-Lymphoid Cell Lines and Their Relevance for the Etiology of Burkitt'S Lymphoma
Q54723898	Phosphorylation of large tumour antigen by cdc2 stimulates SV40 DNA replication.
Q36781515	Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells
Q36933037	Phosphorylation patterns of tumour antigens in cells lytically infected or transformed by simian virus 40
Q58073315	Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73
Q36943796	Polyoma Middle T Antigen Requires Cooperation from Another Gene to Express the Malignant Phenotype In Vivo
Q27310118	Polyoma small T antigen triggers cell death via mitotic catastrophe
Q35013225	Polyoma virus middle T antigen and its role in identifying cancer-related molecules
Q38574112	Polyomavirus BK and prostate cancer: a complex interaction of potential clinical relevance.
Q36913417	Polyomavirus and simian virus 40 large T antigens bind to common DNA sequences.
Q33336307	Positive selection of candidate tumor-suppressor genes by subtractive hybridization
Q74453662	Possible Relation of p53 and mdm-2 Oncoprotein Expression in Thyroid Carcinoma: A Molecular-Pathological and Immunohistochemical Study on Paraffin-Embedded Tissue
Q36966578	Post-Translational Regulation of the 54K Cellular Tumor Antigen in Normal and Transformed Cells
Q42754709	Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations
Q40528510	Potential approaches for myocardial regeneration
Q45878491	Potential role of DNA polymerase beta in gene therapy against cancer: a case for colorectal cancer
Q37349314	Pre-crisis mouse cells show strain-specific covariation in the amount of 54-kilodalton phosphoprotein and in susceptibility to transformation by simian virus 40
Q35006968	Precise epitope mapping of the murine transformation-associated protein, p53.
Q36941888	Presence in growth-arrested cells of cellular proteins that interact with simian virus 40 small-t antigen
Q41366110	Presence of human papillomavirus sequences in tumour-derived human oral keratinocytes expressing mutant p53
Q28240740	Principles of tumor suppression
Q59140486	Production of a polyclonal antibody raised against recombinant flounder p53 protein
Q87945234	Profiling of Germline Mutations in Major Hotspot Codons of TP53 Using PCR-RFLP
Q93001945	Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma
Q36135501	Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas
Q34285565	Prognostic significance of p53-expression in colorectal carcinoma as measured by a luminometric immunoassay
Q52348330	Programmed Cell Death, from a Cancer Perspective: An Overview.
Q42499203	Proliferative (MIB1, mdm2) Versus Anti-Proliferative (p53) Markers in Head and Neck Cancer. An Immunohistochemical Study
Q39219310	Promoter methylation of the SALL2 tumor suppressor gene in ovarian cancers
Q34444393	Prostate cancer in a transgenic mouse
Q40964578	Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable
Q37514996	Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division
Q45966278	Protein-to-protein interactions: criteria defining the assembly of the enamel organic matrix.
Q35586902	Proteomic analysis of the herpes simplex virus 1 virion protein 16 transactivator protein in infected cells
Q36468283	Proteomic approaches to the study of papillomavirus-host interactions.
Q40462999	Proto‐oncogenes and oncogenes in epidermal neoplasia
Q33924762	Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit.
Q41464734	Purification and partial amino acid sequence analysis of the cellular tumour antigen, p53, from mouse SV40-transformed cells
Q40214503	Purification of p53/55 kinase from nuclear ribonucleoproteins of Namalwa cells
Q47833426	Putting p53 in Context
Q36379182	Quantitation and characterization of a species-specific and embryo stage-dependent 55-kilodalton phosphoprotein also present in cells transformed by simian virus 40
Q36973813	Quantitation of a 55K Cellular Protein: Similar Amount and Instability in Normal and Malignant Mouse Cells
Q36503933	Quantitative Proteomic Analysis of Enriched Nuclear Fractions from BK Polyomavirus-Infected Primary Renal Proximal Tubule Epithelial Cells
Q38147113	RUNX Family Participates in the Regulation of p53-Dependent DNA Damage Response
Q33928142	Radioimmunoassay of the cellular protein p53 in mouse and human cell lines.
Q35237803	Rapid and sensitive quantitative immunoassay for the large simian virus 40 T antigen
Q34360802	Rearrangement of the p53 gene in human osteogenic sarcomas
Q34469114	Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus
Q34441608	Recombinant human MFG-E8 attenuates intestinal injury and mortality in severe whole body irradiation in rats
Q36912292	Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens
Q39322285	Regulation of Metabolic Activity by p53.
Q33928759	Regulation of SV40 DNA replication by phosphorylation of T antigen
Q34252765	Regulation of Viral Transcription and DNA Replication by the SV40 Large T Antigen
Q35108767	Regulation of p53 level by UBE4B in breast cancer
Q36972504	Regulation of the Cellular p53 Tumor Antigen in Teratocarcinoma Cells and Their Differentiated Progeny
Q33943437	Regulation of the G2/M transition by p53.
Q33920419	Relationship among Tau antigens isolated from various lines of simian virus 40-transformed cells
Q28645822	Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product
Q36832377	Requirements for species-specific papovavirus DNA replication.
Q30329984	Rescuing the function of mutant p53.
Q45152311	Resistance to viral infection of super p53 mice.
Q36710840	Restoration of wild-type p53 function in human cancer: relevance for tumor therapy.
Q30831001	Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
Q39169881	Restoration of wild-type p53 in drug-resistant mouse breast cancer cells leads to differential gene expression, but is not sufficient to overcome the malignant phenotype.
Q38213115	Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy.
Q36277435	Restriction point control of cell growth by a labile protein: evidence for increased stability in transformed cells
Q45203088	Retinoblastoma in transgenic mice
Q33693631	Retinoblastoma in transgenic mice: models of hereditary retinoblastoma
Q36692841	Retinoblastoma protein and simian virus 40-dependent immortalization of human fibroblasts
Q54033603	Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain.
Q39205536	Reviving the guardian of the genome: Small molecule activators of p53.
Q37690890	Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
Q33603506	Role of p53 assessment in management of Barrett's esophagus
Q41515342	Role of p53 in apoptosis.
Q38883419	Role of p53 isoforms and aggregations in cancer
Q36941216	Role of the p53 Protein in Cell Proliferation as Studied by Microinjection of Monoclonal Antibodies
Q92257837	Roles of p53 Family Structure and Function in Non-Canonical Response Element Binding and Activation
Q36400820	Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells
Q40936277	Roots and perspectives of contemporary papillomavirus research
Q24338301	Rotavirus-encoded nonstructural protein 1 modulates cellular apoptotic machinery by targeting tumor suppressor protein p53
Q67240449	SV40 Early mutants that are defective for viral DNA synthesis but competent for transformation of cultured rat and simian cells
Q41396801	SV40 T antigen and the exocytotic pathway
Q59082218	SV40 T antigen binds specifically to a cellular 53 K protein in vitro
Q38295645	SV40 T-antigen as a dual oncogene: structure and function of the plasma membrane-associated population
Q72646037	SV40 antitumor sera that directly immunoprecipitate small-t-associated cellular proteins
Q28282761	SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation
Q47289313	SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000.
Q43749432	SV40-transformed cells express SV40 T antigen-related antigens on the cell surface
Q37345587	SV40: Cell transformation and tumorigenesis
Q38072351	Senescence regulation by the p53 protein family
Q35237665	Separation of lytic and transforming functions of the simian virus 40 A region: two mutants which are temperature sensitive for lytic functions have opposite effects on transformation
Q36854935	Sequences from polyomavirus and simian virus 40 large T genes capable of immortalizing primary rat embryo fibroblasts
Q35688697	Sequential stimulation of cellular RNA synthesis in polyoma-infected mouse kidney cell cultures
Q36924904	Signal-dependent translocation of simian virus 40 large-T antigen into rat liver nuclei in a cell-free system
Q39748728	Simian Virus 40 Infection of Humans
Q36686025	Simian virus 40 (SV40) T-antigen mutations in tumorigenic transformation of SV40-immortalized human uroepithelial cells
Q33292433	Simian virus 40 T antigen can regulate p53-mediated transcription independent of binding p53.
Q36802646	Simian virus 40 T antigen can transcriptionally activate and mediate viral DNA replication in cells which lack the retinoblastoma susceptibility gene product
Q37333985	Simian virus 40 T-antigen-mediated gene regulation in enterocytes is controlled primarily by the Rb-E2F pathway
Q40307810	Simian virus 40 T-antigen-related cell surface antigen: serological demonstration on simian virus 40-transformed monolayer cells in situ
Q40307207	Simian virus 40 T-antigen: identification of tryptic peptides in the C-terminal region and definition of the reading frame
Q36797245	Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding
Q35236017	Simian virus 40 gene A regulation of cellular DNA synthesis. II. In nonpermissive cells
Q36832198	Simian virus 40 host range/helper function mutations cause multiple defects in viral late gene expression
Q24308996	Simian virus 40 large T antigen affects the Saccharomyces cerevisiae cell cycle and interacts with p34CDC28
Q35831951	Simian virus 40 large T antigen contains two independent activities that cooperate with a ras oncogene to transform rat embryo fibroblasts
Q36854039	Simian virus 40 large T antigen oligomers: analysis of electrophoresis in the absence of detergent
Q40064685	Simian virus 40 large T antigen stably complexes with a 185-kilodalton host protein
Q24305356	Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1
Q36945232	Simian virus 40 large T-antigen point mutants that are defective in viral DNA replication but competent in oncogenic transformation
Q40108931	Simian virus 40 large T-antigen-dependent DNA replication is activated by protein phosphatase 2A in vitro.
Q36688604	Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products
Q42599235	Simian virus 40 mutants with amino-acid substitutions near the amino terminus of large T antigen
Q36855375	Simian virus 40 origin DNA-binding domain on large T antigen.
Q36905896	Simian virus 40 sequences between 0.168 and 0.424 map units are not required for abortive transformation
Q39876425	Simian virus 40 small t antigen activates the carboxyl-terminal transforming p53-binding domain of large T antigen.
Q36906843	Simian virus 40 tumor antigen: isolation of the origin-specific DNA-binding domain
Q34255887	Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum
Q45734015	Simian virus-40 infection inhibits DNA damage-induced enhancement of CD95 expression and function.
Q38993512	SirT3 and p53 Deacetylation in Aging and Cancer
Q36902524	Site-directed mutagenesis of the simian virus 40 large T-antigen gene: replication-defective amino acid substitution mutants that retain the ability to induce morphological transformation
Q37142905	Small DNA tumor viruses: large contributors to biomedical sciences
Q64374754	Small size, big impact: how studies of small DNA tumour viruses revolutionized biology
Q34714730	Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation
Q24651380	Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy
Q27014977	Smoking, p53 mutation, and lung cancer
Q33964955	Species-specific elements in the large T-antigen J domain are required for cellular transformation and DNA replication by simian virus 40
Q67290242	Specific DNA binding activity of T antigen subclasses varies among different SV40-transformed cell lines
Q40141165	Specific interaction of simian virus 40 large T antigen with cellular chromatin and nuclear matrix during the course of infection
Q72924819	Specific interaction of the SV40 T antigen-cellular p53 protein complex with SV40 DNA
Q33999909	Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors
Q36780095	Spontaneous rearrangement of integrated simian virus 40 DNA in nine transformed rodent cell lines
Q38335406	Sprouty 2 binds ESCRT-II factor Eap20 and facilitates HIV-1 gag release
Q41020740	Stabilization of p53 by adenovirus E1A occurs through its amino-terminal region by modification of the ubiquitin-proteasome pathway
Q36936688	Stabilization of the 53,000-Dalton Nonviral Tumor Antigen Is Not Required for Transformation by Simian Virus 40
Q36907734	Stabilization of the large T protein in temperature-independent (type A) FR 3T3 rat cells transformed with the simian virus 40 tsA30 mutant
Q40040456	Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences
Q36730106	Stoichiometry of cellular and viral components in the polyomavirus middle-T antigen-tyrosine kinase complex
Q36932873	Stoichiometry of large T antigen and pp53 in complexes isolated from simian virus 40-transformed rat cells
Q34076012	Strategies for manipulating the p53 pathway in the treatment of human cancer.
Q37794096	Stressin' Sestrins take an aging fight
Q36882128	Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma
Q41792117	Structural analysis of the interaction between Hsp90 and the tumor suppressor protein p53.
Q41428303	Structural prerequisites of simian virus 40 large T antigen for the maintenance of cell transformation
Q36924945	Structure and biochemical functions of four simian virus 40 truncated large-T antigens
Q36927941	Structure and synthesis of a simian virus 40 super T-antigen
Q36931075	Study of the Functional Activities Concomitantly Retained by the 115,000 M r Super T Antigen, an Evolutionary Variant of Simian Virus 40 Large T Antigen Expressed in Transformed Rat Cells
Q41484312	Studying the interaction of polyoma virus middle T antigen with cellular proteins
Q41648413	Suppression of human nasopharyngeal carcinoma cell growth in nude mice by the wild-type p53 gene
Q36350167	Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies.
Q44910351	Suppression of platelet-derived growth factor alpha- and beta-receptor mRNA levels in human fibroblasts by SV40 T/t antigen
Q80212337	Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model
Q35967111	Surf the post-translational modification network of p53 regulation
Q31904803	Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha
Q45798213	Synthesis and processing of simian virus 40-specific RNA in adenovirus-infected, simian virus 40-transformed human cells
Q44247769	Systemic lupus erythematosus and uterine cervical neoplasia
Q24645091	T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus
Q34662543	T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis
Q36900316	T-antigen-DNA polymerase alpha complex implicated in simian virus 40 DNA replication
Q55483973	TP53 Gene Mutations and 17p Deletions in Human Astrocytomas
Q36081911	TP53 gene mutations and protein accumulation in primary vaginal carcinomas
Q36135944	TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material
Q38199075	TP53 mutations in human cancer: database reassessment and prospects for the next decade
Q34559185	TP53 mutations in nonsmall cell lung cancer
Q40742654	TP53 tumor-suppressor gene and human carcinogenesis
Q46408321	TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear.
Q33937962	Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins
Q33655329	Targeting p53 for Novel Anticancer Therapy
Q37177586	Targeting the MDM2-p53 interaction for cancer therapy
Q91643844	Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors
Q35795073	Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils
Q33657519	Targeting tumor suppressor networks for cancer therapeutics
Q36831228	Temperature-sensitive mutants identify crucial structural regions of simian virus 40 large T antigen
Q40722479	The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.
Q24300207	The ASPP proteins complex and cooperate with p300 to modulate the transcriptional activity of p53
Q34246710	The DNA damage response in viral-induced cellular transformation
Q37785502	The DNA damage response—Repair or despair?
Q91816686	The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer
Q35851139	The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors
Q33817088	The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction
Q42323049	The Evolution of TP53 Mutations: From Loss-of-Function to Separation-of-Function Mutants
Q50448531	The Evolution of Tumor Formation in Humans and Mice with Inherited Mutations in the p53 Gene.
Q55180659	The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere Structure.
Q24317677	The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Q28079490	The Importance of Physiologically Relevant Cell Lines for Studying Virus-Host Interactions
Q36430168	The P53 pathway: what questions remain to be explored?
Q38896065	The Paradox of p53: What, How, and Why?
Q34549700	The Promise of Proteomics in the Study of Oncogenic Viruses
Q41528803	The Retinoblastoma Protein: A Master Regulator of Cell Cycle, Differentiation and Apoptosis
Q40271232	The SV40 a gene product is required for the production of a 54,000 MW cellular tumor antigen
Q36827839	The ability of large T antigen to complex with p53 is necessary for the increased life span and partial transformation of human cells by simian virus 40.
Q33932011	The abnormal location of cytoplasmic SV40 large T is not caused by failure to bind to DNA or to p53.
Q38186535	The aggregation of mutant p53 produces prion-like properties in cancer
Q40039307	The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells.
Q31816068	The angiotensin II-dependent nuclear translocation of Stat1 is mediated by the Jak2 protein motif 231YRFRR.
Q53542021	The cellular oncogene p53 can be activated by mutagenesis.
Q40627208	The clinical relevance of the p53 tumour suppressor gene
Q36764924	The clinical significance of autoantibodies in gastrointestinal malignancies: an overview
Q40381238	The clinical significance of p53 aberrations in human tumours
Q34903861	The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53.
Q35191541	The complex interactions of p53 with target DNA: we learn as we go.
Q43941701	The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo
Q37808166	The critical protein interactions and structures that elicit growth deregulation in cancer and viral replication
Q37859721	The dual role of p53: DNA protection and antioxidant.
Q34402080	The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth
Q33593937	The emerging p53 gene family
Q26742058	The expanding regulatory universe of p53 in gastrointestinal cancer
Q24645732	The first 30 years of p53: growing ever more complex
Q34180336	The genetics and genomics of cancer
Q40279927	The genome of human papovavirus BKV
Q34142403	The history of p53. A perfect example of the drawbacks of scientific paradigms
Q24610004	The history of tumor virology
Q33888765	The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis
Q39595067	The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.
Q40138359	The immunopathology of SV40-induced transformation
Q40088889	The impact of p53 on the early stage replication of retrovirus.
Q39729519	The implications of embryonic gene expression in neoplasia
Q37182764	The individualization of cancer therapy: the unexpected role of p53.
Q41690979	The initiation of simian virus 40 DNA replication in vitro
Q28252021	The interaction of the hnRNP family member E1B-AP5 with p53
Q33693832	The isoforms of the p53 protein
Q36832483	The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions
Q92701432	The many faces of p53: something for everyone
Q36659029	The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth
Q40076287	The mechanism of cell transformation by SV40 and Polyoma virus
Q40867777	The molecular and genetic characterization of human soft tissue tumors.
Q92062954	The multiple mechanisms that regulate p53 activity and cell fate
Q40605944	The origins of the small DNA tumor viruses
Q28259725	The p53 circuit board
Q36781766	The p53 complex from monkey cells modulates the biochemical activities of simian virus 40 large T antigen
Q36521923	The p53 family in nervous system development and disease
Q48678761	The p53 family: guardians of maternal reproduction
Q40961528	The p53 gene and its role in human brain tumors.
Q53601235	The p53 knowledgebase: an integrated information resource for p53 research.
Q67469552	The p53 tumor suppressor gene. A preliminary clinical study in breast cancer patients
Q37887629	The p53 tumor suppressor protein regulates hematopoietic stem cell fate
Q37751892	The p53 tumour suppressor gene
Q38548852	The p53 tumour suppressor gene
Q34187832	The p53 tumour suppressor protein
Q33922153	The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.
Q41489275	The p53-Bcl-2 connection
Q37503463	The p53-MDM2/MDMX axis - A chemotype perspective
Q35371834	The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation
Q40130414	The pathogenesis of Abelson virus lymphomas of the mouse
Q62497458	The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer
Q53560080	The presence of p53 transformation-related protein in Ab-MuLV transformed cells is required for their development into lethal tumors in mice
Q72314536	The prevalence of different human papillomavirus types and p53 mutations in laryngeal carcinomas: is there a reciprocal relationship?
Q51342055	The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.
Q35978470	The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma
Q34629128	The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology
Q42125689	The relationship of p53 immunostaining to survival in carcinoma of the lung
Q72700246	The relationship of p53 protein and lymph node metastases in invasive breast cancer
Q41193565	The role of DNA repair in the prevention of cancer
Q78244648	The role of autosomal cell apoptosis regulator genes in human spermatogenesis
Q24793695	The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival
Q53569200	The role of gene dosage and genetic transpositions in carcinogenesis
Q35034088	The role of non-ras transforming genes in chemical carcinogenesis
Q41176248	The role of p53 in cell cycle regulation
Q41486644	The role of p53 in growth of mouse fibroblast lines
Q34283469	The role of p53 in human cancer
Q33807833	The role of the E6-p53 interaction in the molecular pathogenesis of HPV.
Q34602545	The significance of immunohistochemistry in the diagnosis and therapy of neoplasms
Q45801434	The specific interaction of the Rous sarcoma virus transforming protein, pp60src, with two cellular proteins
Q37537138	The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
Q33938629	The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein
Q40276689	The transforming genes of SV40 and polyoma
Q41457444	The transforming protein of the MC29-related virus CMII is a nuclear DNA-binding protein whereas MH2 codes for a cytoplasmic RNA-DNA binding polyprotein
Q33490078	The tsA58 simian virus 40 large tumor antigen disrupts megakaryocyte differentiation in transgenic mice.
Q38314522	The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein
Q40677778	The tumor suppressor p53 is bound to RNA by a stable covalent linkage
Q28131694	The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest
Q33384295	The ubiquitin system, disease, and drug discovery
Q33566355	The v-rel oncogene product is complexed to a 40-kDa phosphoprotein in transformed lymphoid cells
Q36779984	The zinc finger region of simian virus 40 large T antigen
Q36695049	The zinc finger region of simian virus 40 large T antigen is needed for hexamer assembly and origin melting
Q84961734	Therapeutic options for treatment of Merkel cell carcinoma
Q38042630	Therapeutic strategies for head and neck cancer based on p53 status
Q91898958	Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia
Q47742599	Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
Q33302913	Thirty years into the genomics era: tumor viruses led the way.
Q37188430	Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222
Q36926635	Time-dependent maturation of the simian virus 40 large T antigen-p53 complex studied by using monoclonal antibodies
Q28255819	To die or not to die: how does p53 decide?
Q34983824	To kill or be killed: viral evasion of apoptosis
Q34979520	Topoisomerase activity associated with SV40 large tumor antigen
Q38486723	Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation
Q35127707	Transactivation of Human cdc2 Promoter by Adenovirus E1A
Q27679224	Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code
Q38341700	Transcription factor E4TF1 contains two subunits with different functions
Q36777349	Transcription regulation by mutant p53.
Q39005896	Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.
Q37113939	Transcriptional and Transforming Activities of the Adenovirus E1A Proteins
Q38408993	Transcriptome profiling the gills of amoebic gill disease (AGD)-affected Atlantic salmon (Salmo salar L.): a role for tumor suppressor p53 in AGD pathogenesis?
Q36217854	Transfection of neonatal rat Schwann cells with SV-40 large T antigen gene under control of the metallothionein promoter
Q41601530	Transformation and radiosensitivity of human diploid skin fibroblasts transfected with SV40 T-antigen mutants defective in RB and P53 binding domains
Q44840448	Transformation and radiosensitivity of human diploid skin fibroblasts transfected with activated ras oncogene and SV40 T-antigen
Q40307671	Transformation of Primary Hamster Brain Cells with JC Virus and Its DNA
Q36919634	Transformation of precrisis human cells by the simian virus 40 cytoplasmic-localization mutant pSVCT3 is accompanied by nuclear T antigen
Q40106989	Transformation-Associated Tumor Antigens
Q41505517	Transforming growth factor-beta 1 enhances serum-induced dephosphorylation of the P53 protein in cell lines growth-inhibited by this factor
Q83169251	Transgenic models for prostate cancer research
Q34164124	Transgenic models of retinoblastoma: what they tell us about its cause and treatment
Q47973774	Transgenic rodent mutation/cancer bioassays: cell cycle control, cell proliferation and apoptosis as modifiers of outcome
Q80221850	Treatment options for the recurrent odontogenic keratocyst
Q35902311	Truncated N-terminal mutants of SV40 large T antigen as minimal immortalizing agents for CNS cells
Q34324683	Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions
Q38026794	Tumor suppressive pathways in the control of neurogenesis.
Q37289549	Tumor suppressor genes and cancer of the human nervous system
Q41625163	Tumor suppressor genes and human cancer
Q40568049	Tumor suppressor genes and their roles in breast cancer
Q40456928	Tumor suppressor genes in human thyroid neoplasms: p53 mutations are associated undifferentiated thyroid cancers
Q36847017	Tumor suppressor genes: a new era for molecular genetic studies of cancer
Q53449845	Tumor suppressor p53 gene forms multiple isoforms: evidence for single locus origin and cytoplasmic complex formation with heat shock proteins.
Q34314048	Tumor suppressor p53 mutations and breast cancer: a critical analysis
Q40130058	Tumor viruses and early mouse embryos
Q38824332	Tumor-Suppressor Functions of the TP53 Pathway
Q30499489	Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers
Q41575783	Tumorigenic conversion of human mesothelial cells as a consequence of platelet-derived growth factor-A chain overexpression
Q40044331	Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation.
Q41809596	Tumourigenesis associated with the p53 tumour suppressor gene
Q48033225	Turning the key on p53.
Q33807787	Twenty years of p53 research: structural and functional aspects of the p53 protein
Q36980764	Two Distinct Mechanisms Regulate the Levels of a Cellular Tumor Antigen, p53
Q44676897	Two cellular proteins that immunoprecipitate with the transforming protein of Rous sarcoma virus
Q36896709	Two classes of transformation-deficient, immortalization-positive simian virus 40 mutants constructed by making three-base insertions in the T antigen gene
Q59074470	Two different viral transforming proteins bind the same host tumour antigen
Q33865112	Two different, mutually exclusively distributed, TP53 mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?
Q40129418	Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen.
Q22251289	Two genetic hits (more or less) to cancer
Q36887574	Two integrated partial repeats of simian virus 40 together code for a super-T antigen
Q24609948	UV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells
Q27015641	Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
Q64236647	Understanding p53 functions through p53 antibodies
Q37680206	Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activity
Q34322386	Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?
Q36743177	Uniform cell-autonomous tumorigenesis of the choroid plexus by papovavirus large T antigens
Q34110697	Update on human polyomaviruses and cancer
Q47111189	Updates from the TP53 universe
Q34170074	Vaccines and immunotherapeutics for the treatment of malignant disease
Q37496628	Variability in APOE genotype status in human-derived cell lines: a cause for concern in cell culture studies?
Q37087404	Versatile functions of p53 protein in multicellular organisms
Q33894872	View and review on viral oncology research
Q41708689	Viral and cellular oncogene expression during progressive malignant transformation of SV40 transformed human fibroblasts
Q33846198	Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease
Q44491628	Viral genotypes and p53 expression in Epstein-Barr virus-associated primary malignant lymphomas of the intestines
Q41510729	Viral inhibitors of apoptosis
Q24538223	Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.
Q39576424	Viral oncoproteins discriminate between p53 and the p53 homolog p73.
Q41374895	Virocrine transformation
Q36318145	Viruses - seeking and destroying the tumor program
Q30384388	Viruses and human cancers: a long road of discovery of molecular paradigms.
Q24653900	Viruses associated with human cancer
Q36304840	Visualizing viral protein structures in cells using genetic probes for correlated light and electron microscopy
Q73066904	WAF1 expression and p53 mutations in human colorectal cancers
Q38043443	What We Know about the Molecular Genetics of Central Nervous System (CNS) Tumours in Malaysia
Q91771327	What's knowledge is prologue: celebrating the 40th anniversary of the p53 discovery
Q37582777	When mutants gain new powers: news from the mutant p53 field.
Q37788083	Whether to target single or multiple CDKs for therapy? That is the question
Q37811898	Why do viruses cause cancer? Highlights of the first century of human tumour virology
Q35830939	Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue
Q36618628	Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9
Q44703400	Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication
Q40872252	Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA.
Q39822156	Wild-type p53 enhances efficiency of simian virus 40 large-T-antigen-induced cellular transformation
Q40043948	Wild-type p53 is not a negative regulator of simian virus 40 DNA replication in infected monkey cells.
Q26999402	Zebrafish sex: a complicated affair
Q90108778	Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination
Q73571149	[An immunohistochemistry study of p53 protein in squamous cell carcinoma of the larynx]
Q80076298	[Molecular biological and immunohistochemical analysis of tp53 in human ameloblastomas]
Q90070454	[Update on Li-Fraumeni syndrome]
Q33807825	mdm2: a bridge over the two tumour suppressors, p53 and Rb.
Q28565821	p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen
Q35326348	p53 Family: Role of Protein Isoforms in Human Cancer
Q90510724	p53 Overexpression in Oral Mucosa in Relation to Shisha Smoking in Syria and Lebanon
Q41313953	p53 Phosphorylation: biochemical and functional consequences
Q34313764	p53 Research: the past thirty years and the next thirty years.
Q73215749	p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. An immunohistochemical and SSCP analysis
Q72680112	p53 accumulation in polynuclear-giant-cells
Q44581576	p53 and DNA polymerase alpha compete for binding to SV40 T antigen
Q35185411	p53 and E2F-1 cooperate to mediate apoptosis
Q33853843	p53 and TAp63 participate in the recombination-dependent pachytene arrest in mouse spermatocytes
Q38294077	p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches
Q37502697	p53 and little brother p53/47: linking IRES activities with protein functions
Q55002919	p53 and metabolism: from mechanism to therapeutics.
Q36915110	p53 and retinoblastoma pathways in bladder cancer.
Q55084411	p53 and the Viral Connection: Back into the Future ‡.
Q37242078	p53 as a therapeutic target.
Q36356298	p53 attenuates AKT signaling by modulating membrane phospholipid composition
Q37619644	p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression.
Q42281236	p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas
Q74122440	p53 expression and p53 gene mutation in oral cancer and dysplasia
Q41947345	p53 expression in colorectal tumors.
Q71603631	p53 expression in odontogenic keratocyst epithelium
Q44259985	p53 expression is common in malignant mesothelioma
Q34206213	p53 functional assays: detecting p53 mutations in both the germline and in sporadic tumours
Q34254691	p53 functions as a cell cycle control protein in osteosarcomas
Q40370722	p53 gene mutations and photocarcinogenesis
Q48428560	p53 gene mutations in primary lung tumors are conserved in brain metastases
Q42787579	p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma
Q36079809	p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder
Q42281269	p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance
Q73130677	p53 immunostaining and image cytometry DNA analysis in precancerous and cancerous squamous epithelial lesions of the larynx
Q33358202	p53 in cell invasion, podosomes, and invadopodia
Q35982948	p53 in colorectal cancer: clinicopathological correlation and prognostic significance
Q77957211	p53 induction in normal human skin in vitro following exposure to solar simulated UV and UV-B irradiation
Q24319034	p53 isoforms can regulate p53 transcriptional activity.
Q91701515	p53 modifications: exquisite decorations of the powerful guardian
Q33750337	p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer
Q36690312	p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice
Q36622335	p53 mutations in urinary bladder cancer.
Q49164152	p53 mutations occur in clinical, but not latent, human prostate carcinoma
Q41607022	p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia
Q48243360	p53 orchestrates DNA replication restart homeostasis by suppressing mutagenic RAD52 and POLθ pathways.
Q40848687	p53 overexpression in Ewing's sarcoma/primitive neuroectodermal tumour is an uncommon event
Q53559051	p53 protein and control of growth.
Q55483225	p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.
Q72046282	p53 protein expression in cutaneous T-cell lymphomas
Q73144803	p53 protein expression in ductal carcinoma in situ (DCIS) of the breast
Q35994464	p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor
Q36294933	p53 protein expression in nephroblastomas: a predictor of poor prognosis
Q37107115	p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts
Q45122733	p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation.
Q37821711	p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells
Q35329162	p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells
Q35360570	p53 transformation-related protein: detection of an associated phosphotransferase activity
Q42440449	p53 tumor suppressor gene protein expression in premalignant and malignant skin lesions of kidney transplant recipients
Q37049524	p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer
Q41640484	p53 tumor-suppressor gene: clues to molecular carcinogenesis
Q89783061	p53's Extended Reach: The Mutant p53 Secretome
Q47702659	p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole
Q42362115	p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance
Q35103179	p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome
Q37610416	p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells
Q38102472	p53-based therapeutics for head and neck squamous cell carcinoma
Q40873109	p53-catalyzed annealing of complementary single-stranded nucleic acids
Q34305233	p53-dependent apoptosis pathways.
Q34424487	p53-dependent growth arrest of REF52 cells containing newly amplified DNA.
Q34609247	p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus
Q36443527	p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Q24338379	p53: 25 years after its discovery
Q94671691	p53: 800 million years of evolution and 40 years of discovery
Q40564007	p53: a cellular Achilles' heel revealed.
Q37248542	p53: a molecular marker for the detection of cancer.
Q91651435	p53: a tumor suppressor hiding in plain sight
Q45888635	p53: balancing tumour suppression and implications for the clinic
Q83365205	p53: more research and more questions
Q91771321	p53: not just a tumor suppressor
Q37824262	p53: the attractive tumor suppressor in the cancer research field
Q36163707	p53: twenty five years understanding the mechanism of genome protection
Q30595453	p63 and p73: old members of a new family
Q35227440	p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.
Q40774641	p73 is a growth-regulated protein in vascular smooth muscle cells and is present at high levels in human atherosclerotic plaque
Q39589009	pRB-dependent, J domain-independent function of simian virus 40 large T antigen in override of p53 growth suppression
Q40650649	trans activation of type 1 interferon promoters by simian virus 40 T antigen

P6179	Dimensions Publication ID	1001770301
P356	DOI	10.1038/278261A0
P953	full work available at URL	http://www.nature.com/articles/278261a0
		http://www.nature.com/articles/278261a0.pdf
P3181	OpenCitations bibliographic resource ID	1347156
P698	PubMed publication ID	218111

P50	author	David P. Lane	Q909289
P2093	author name string	L. V. Crawford
P2860	cites work	Transformation of BALB/c-3T3 cells by tsA mutants of simian virus 40: temperature sensitivity of the transformed phenotype and retransofrmation by wild-type virus	Q37602234
		An immunochemical investigation of SV40 T antigens. 1. Production properties and specificity of rabbit antibody to purified simian virus 40 large-T antigen	Q39495337
		The genome of simian virus 40.	Q40142651
		Antiserum to polyacrylamide gel-purified simian virus 40 T antigen	Q40155471
		Mutants of SV40 with an altered small t protein are reduced in their ability to transform cells	Q40158462
		Methods for fractionation and scintillation counting of radioisotope-labeled polyacrylamide gels	Q71587915
		Organization and expression of early genes of simian virus 40	Q33954047
		Spliced early mRNAs of simian virus 40	Q33967138
		Complete nucleotide sequence of SV40 DNA	Q34122821
		Initiation and maintenance of cell transformation by simian virus 40: a viral genetic property	Q35070561
		Expression of simian virus 40 early genes in transformed rat cells is correlated with maintenance of the transformed phenotype	Q35995573
		The small subunit of HL-A antigens is beta 2-microglobulin	Q36272738
		Phosphorylation of T-antigen and control T-antigen expression in cells transformed by wild-type and tsA mutants of simian virus 40	Q36493723
		Simian virus 40 functions required for the establishment and maintenance of malignant transformation	Q36532307
		Regulation of tumor antigen synthesis by simain virus 40 gene A	Q36537613
		Studies on nondefective adenovirus-simian virus 40 hybrid viruses. I. A newly characterized simian virus 40 antigen induced by the Ad2+ND 1 virus	Q36578182
		Identification of simian virus 40 tumor and U antigens	Q37581413
		Cell-free translation of simian virus 40 early messenger RNA coding for viral T-antigen	Q37581427
		Large and small tumor antigens from simian virus 40 have identical amino termini mapping at 0.65 map units	Q37585547
P433	issue	5701
P407	language of work or name	English	Q1860
P921	main subject	viral antigens	Q66058032
		neoplasm antigens	Q76832457
		viral transformation	Q17162815
P304	page(s)	261-3
P577	publication date	1979-03-15
P1433	published in	Nature	Q180445
P1476	title	T antigen is bound to a host protein in SV40-transformed cells
		T antigen is bound to a host protein in SY40-transformed cells
P478	volume	278

T antigen is bound to a host protein in SY40-transformed cells

scientific article (publication date: 15 March 1979)

Reverse relations